BVT.2733, a Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, Attenuates Obesity and Inflammation in Diet-Induced Obese Mice

BACKGROUND: Inhibition of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is being pursued as a new therapeutic approach for the treatment of obesity and metabolic syndrome. Therefore, there is an urgent need to determine the effect of 11β-HSD1 inhibitor, which suppresses glucocorticoid action, o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Long, Liu, Juan, Zhang, Aisen, Cheng, Peng, Zhang, Xiao, Lv, Shan, Wu, Lin, Yu, Jing, Di, Wenjuan, Zha, Juanmin, Kong, Xiaocen, Qi, Hanmei, Zhong, Yi, Ding, Guoxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388048/
https://www.ncbi.nlm.nih.gov/pubmed/22768329
http://dx.doi.org/10.1371/journal.pone.0040056

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388048/
https://www.ncbi.nlm.nih.gov/pubmed/22768329
http://dx.doi.org/10.1371/journal.pone.0040056

Ejemplares similares